Cancer vaccines utilizing mRNA vaccine technology have such potential that ARPA-H, a newly established White House-originated program, has made it the focus of
Kluger works in the broad fields of bioinformatics, machine learning, and applied mathematics to develop approaches for analyzing large biological data sets.
One of the problems with the new subgroup of HER2 low tumors is that using current assays to measure low levels "is like weighing mice on a scale built for elephants," says one expert.